[{"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "85357", "recalling_firm": "Noven Therapeutics, LLC", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-1249-2020", "product_description": "Daytrana (methylphenidate transdermal system) Delivers 30 mg over 9 hours (3.3 mg/hr) 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC Miami, FL 33186, NDC 68968-5555-3", "product_quantity": "14,142 30-count boxes", "reason_for_recall": "Defective Delivery System: Out of specification for mechanical peel and shear.", "recall_initiation_date": "20200331", "center_classification_date": "20200417", "termination_date": "20240617", "report_date": "20200429", "code_info": "Lots: 86355 Exp. 07/2020; 86356 Exp.08/2020; 86550 Exp. 07/2020; 87348 Exp. 01/2021; 87965 Exp. 01/2021"}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1187-2020", "product_description": "Bi-Est (8:2) Progest/Test 2/80/3 mg/mL cream 30 gm tube, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 tube", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45098 Discard by: 8/16/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0721-2020", "product_description": "CLON 100MCG/MORP 12MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@24 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84516", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Natiowide", "recall_number": "D-0639-2020", "product_description": "Glenmark Ranitidine Tablets USP 150 mg Rx Only 60 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ   NDC 68462-248-60", "product_quantity": "208,668 bottles", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191217", "center_classification_date": "20200105", "report_date": "20200115", "code_info": "7701164A  7701471A  7701670B  7701827A  7702242A  7702705A  7702947A  7703408A  7704494A  7704495A  19190289  19190342  19190372  7702737A"}, {"status": "Terminated", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86498", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "N/A", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA", "recall_number": "D-0017-2021", "product_description": "Ranitidine 300 mg, 30 Tabs bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534  NDC 61919-455-30", "product_quantity": "26 bottles", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20200115", "center_classification_date": "20201005", "termination_date": "20201207", "report_date": "20201014", "code_info": "Lot: 29JA1915 Exp. 09/30/2021"}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85306", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Bulk product was distributed to one re-packager in California.", "recall_number": "D-1101-2020", "product_description": "LOSARTAN POTASSIUM TABLETS, USP 50 mg, Bulk, Rx only,  For Further Manufacturing, Packing or Repackaging only, Manufactured by: Arrow Pharma (Malta) Ltd., Birzebbugia, Malta NDC 0591-3746-00", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.", "recall_initiation_date": "20200325", "center_classification_date": "20200407", "report_date": "20200415", "code_info": "Lots 1195625A, 1195624A, 1195623A, exp. date 03/2020"}, {"status": "Ongoing", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85781", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "N/A", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1352-2020", "product_description": "amneal Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 1000 tablets bottles, Distributed by: Amneal Pharmaceuticals LLC Bridgewater, NJ 08807   NDC 53746-0178-10", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level", "recall_initiation_date": "20200529", "center_classification_date": "20200625", "report_date": "20200701", "code_info": "HF08618A 6/30/2020  HF08718A 6/30/2020  HF15418A 7/31/2020  HF15518A 7/31/2020  HH11818A 9/30/2020  HJ00818A 9/30/2020  HJ00918A 9/30/2020  HJ01018A 9/30/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0707-2020", "product_description": "BUP 40MG/FENT 1200MCG/SUF 400MCG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12102019@4 Exp. 12/19/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Woodbine", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86233", "recalling_firm": "Grato Holdings, Inc.", "address_1": "201 Apple Blvd", "address_2": "N/A", "postal_code": "51579-1503", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "One direct account in UT", "recall_number": "D-1558-2020", "product_description": "HGH Vitality Homeopathic, 90 tablets, NDC 43742-1299-1, Dist. by Deseret Biologicals, Inc. 469 W. Parkland Drive, Sandy, UT 84070, NDC: 43742-1299-1", "product_quantity": "850 bottles", "reason_for_recall": "Labeling: Error on Declared Strength", "recall_initiation_date": "20200716", "center_classification_date": "20200829", "termination_date": "20220917", "report_date": "20200909", "code_info": "Lot P2613"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85888", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico", "recall_number": "D-1377-2020", "product_description": "Nystatin Oral Suspension, USP 500,000 units/5mL Cup,  Delivers 5 mL, Rx Only, Manufactured by: VistaPharm, Largo, FL 33771, a) NDC 66689-037-50 (individual cup NDC: 66689-037-01); b) 66689-037-99.", "product_quantity": "380,700 cups", "reason_for_recall": "Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.", "recall_initiation_date": "20200623", "center_classification_date": "20200708", "termination_date": "20220928", "report_date": "20200715", "code_info": "Lot #: a) 619800, Exp. 12/31/2020; 626200, Exp. 01/31/2021; b) 619800X,Exp. 12/31/2020; 626200X, Exp. 01/31/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0684-2020", "product_description": "BUP 15MG/CLON 400MCG/ FENT 6000MCG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12132019@5 Exp. 12/22/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85018", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within United States and Puerto Rico", "recall_number": "D-0860-2020", "product_description": "Well at Walgreens Sodium Chloride Ophthalmic Ointment USP, 5%, 3.5 g tubes, Distributed by: Walgreen Co. 200 Wilmot Rd., Deerfield, IL 60015. NDC 0363-9050-00.", "product_quantity": "24 tubes", "reason_for_recall": "Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of construction for the tube.", "recall_initiation_date": "20200221", "center_classification_date": "20200227", "termination_date": "20220728", "report_date": "20200304", "code_info": "Lot #:8G59A, Exp. Date 06/2021"}, {"country": "United States", "city": "Decatur", "address_1": "1316 Commerce Dr", "reason_for_recall": "Subpotent", "address_2": "", "product_quantity": "a) 597 jars; b) 411 jars; c) 5 jars; d) 1004 jars: e) 76 jars; f) 1592 jars", "code_info": "Lots: a) 1804030048 Exp. 06/06/2020; 1712270019, 1802160017 Exp. 08/06/2020; 1804300021, 1806270007, 1808090056, 1904290047 Exp. 04/16/2021; 1810190004, 1812200072, 1901250024 Exp. 08/13/2021;   1902190028, 1907260018 Exp 09/14/2021;     b) 1804030049 Exp. 06/06/2020; 1712270020, 1802160018 Exp. 08/06/2020;   1804300022, 1806270008, 1808090057, 1904290048 Exp. 04/16/2021; 1810190005, 1812200073, 1901250025 Exp. 08/13/2021; 1902190029, 1907260019 Exp. 09/14/2021;     c) 1802160022 Exp. 08/06/2020; 1810190009, 1812200077 Exp. 08/13/2021; 1907260023 Exp. 09/14/2021;     d) 1804030050 Exp 06/06/2020; 1712270021, 1802160019 Exp. 08/06/2020;  1804300023, 1806270009, 1808090058, 1904290049 Exp 04/16/2021; 1810190006, 1812200074, 1901250026 Exp. 08/13/2021; 1902190030, 1907260020 Exp. 09/14/2021;     e) 1802160021 Exp. 08/06/2020; 1804300025, 1806270011, 1808090060 Exp. 04/16/2021; 1810190008 Exp. 08/13/2021; 1812200076 Exp. 08/13/2021; 1901250028 Exp. 08/13/2021; 1902190031 Exp. 09/14/2021; 1907260022 Exp. 09/14/2021; f) 1712270022 Exp. 08/06/2020; 1802160020 Exp. 08/06/2020; 1804030051 Exp. 06/06/2020; 1804300024 Exp. 04/16/2021; 1806270010 Exp. 04/16/2021; 1808090059 Exp. 04/16/2021; 1810190007 Exp. 08/13/2021; 1812200075 Exp. 08/13/2021; 1901250027 Exp. 08/13/2021; 1904290050 Exp. 04/16/2021; 1907260021 Exp. 09/14/2021", "center_classification_date": "20200115", "distribution_pattern": "United States, Australia, Canada, Israel, Philippines, Taiwan.", "state": "AL", "product_description": "Estriol USP Micronized a) 100 gm NDC 62991-2159-04; b) 1 gm NDC 62991-2159-01; c) 1 kg NDC 62991-2159-06; d) 25 gm NDC 62991-2159-03; e) 500 gm NDC 62991-2159-05; f) 5 gm NDC 62991-2159-02, Rx Only Repackaged by: Letco Medical, LLC. Decatur, AL 35601", "report_date": "20200122", "classification": "Class II", "openfda": {}, "recalling_firm": "Letco Medical LLC", "recall_number": "D-0780-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84686", "termination_date": "20210407", "more_code_info": "", "recall_initiation_date": "20200110", "postal_code": "35601-7539", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Jenison", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85854", "recalling_firm": "MICHIGAN HERBAL REMEDIES", "address_1": "904 Chicago Dr", "address_2": "", "postal_code": "49428-9351", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide via internet sales,retailers and distributors in the USA", "recall_number": "D-1465-2020", "product_description": "SP, hemp oil, Berry, 300MG CBD,1 FL. OZ (30 ML) bottles, Distributed by: The Spiffy Piff", "product_quantity": "25 bottles", "reason_for_recall": "Chemical contamination: product contains elevated levels of undeclared lead.", "recall_initiation_date": "20200618", "center_classification_date": "20200804", "report_date": "20200812", "code_info": "FG003277", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0693-2020", "product_description": "BUP 20MG/SUF 1000MCG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12172019@10 Exp. 12/26/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Cambridge", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA205874"], "brand_name": ["AURYXIA"], "generic_name": ["FERRIC CITRATE"], "manufacturer_name": ["Akebia Therapeutics, Inc."], "product_ndc": ["59922-631"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TETRAFERRIC TRICITRATE DECAHYDRATE"], "rxcui": ["1594680", "1596023"], "spl_id": ["c7578bda-1b89-4881-95cd-f1201508871f"], "spl_set_id": ["aadd18e0-3752-11e4-8510-0800200c9a66"], "package_ndc": ["59922-631-01"], "is_original_packager": [true], "unii": ["Q91187K011"]}, "product_type": "Drugs", "event_id": "86955", "recalling_firm": "Akebia Therapeutics dba Keryx Biopharmaceutials, Inc", "address_1": "245 1st St", "address_2": "N/A", "postal_code": "02142-1200", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The product was distributed by two major distributors who further distributed the product nationwide and one specialty pharmacy.", "recall_number": "D-0170-2021", "product_description": "Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC., One Marina Park Drive, 12th Floor, Boston, MA  02210, NDC 59922-631-01", "product_quantity": "2,170 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20201209", "center_classification_date": "20201218", "termination_date": "20210901", "report_date": "20201230", "code_info": "Lot Number: 9062, exp. date Feb 2021"}, {"status": "Terminated", "city": "Claremont", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "84279", "recalling_firm": "Natures Rx", "address_1": "310 N Indian Hill Blvd", "address_2": "Ste 600", "postal_code": "91711-4611", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0633-2020", "product_description": "Silver Bullet, Get Bigger and Harder, Works in Minutes, Lasts for Days, 10 male enhancement capsules in blister foil package, 725mg per capsule, Distributed by Silver Bullet Ltd, Golden Springs, CO, USA, UPC: 610877392698.", "product_quantity": "2,800 capsules", "reason_for_recall": "Marketed Without an Approved NDA/ANDA; Product contains undeclared active ingredient - Sildenafil.", "recall_initiation_date": "20191113", "center_classification_date": "20191231", "termination_date": "20230208", "report_date": "20200108", "code_info": "Lot  # 01251ZX1, exp. date 11/2022  UPC: 610877392698"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85018", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within United States and Puerto Rico", "recall_number": "D-0861-2020", "product_description": "CVS Health Sodium Chloride Ophthalmic Ointment USP, 5%, 3.5 g tubes, Distributed By: CVS Pharmacy Inc. One CVS Drive, Woonsocket, RI 02895, NDC 59779-303-01", "product_quantity": "N/A", "reason_for_recall": "Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of construction for the tube.", "recall_initiation_date": "20200221", "center_classification_date": "20200227", "termination_date": "20220728", "report_date": "20200304", "code_info": "Lot #:8G50A, Exp. Date 06/2021"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0939-2020", "product_description": "AscorbiX (Buffered C) Injection, Ascorbix (30ML) 500MG/ML Injectable, For IV, IM, SC Use, Refrigerate, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0226-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 07112019+52635, Exp 1/17/2020; 09092019+52890, Exp 3/17/2020"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1168-2020", "product_description": "Vertigo Off, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200675"], "brand_name": ["LIDOCAINE"], "generic_name": ["LIDOCAINE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-3525"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["LIDOCAINE"], "rxcui": ["1745091"], "spl_id": ["565097f1-4afc-434b-b177-4309d297a6d1"], "spl_set_id": ["4d04052c-3e0a-469a-9265-99604f13e507"], "package_ndc": ["0591-3525-11", "0591-3525-30"], "is_original_packager": [true], "nui": ["N0000175682", "M0000897", "N0000175426", "N0000175976"], "pharm_class_epc": ["Amide Local Anesthetic [EPC]", "Antiarrhythmic [EPC]"], "pharm_class_cs": ["Amides [CS]"], "pharm_class_pe": ["Local Anesthesia [PE]"], "unii": ["98PI200987"]}, "product_type": "Drugs", "event_id": "86017", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide United States", "recall_number": "D-1492-2020", "product_description": "Lidocaine Patch 5%, packaged in 30-count cartons, Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA, NDC 0591-3525-30", "product_quantity": "28,596 cartons", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp date on the individual transdermal pouches but not in the carton.", "recall_initiation_date": "20200714", "center_classification_date": "20200810", "termination_date": "20210707", "report_date": "20200819", "code_info": "Carton Lot # 1383513B, Patch Lot # 1383513, Exp date 03/2022"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0951-2020", "product_description": "Dexamethasone (LA) Injectable Suspension, DEXAMETHASONE LA [10ML] 16MG  INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0630-1", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 10022019+53002, Exp 10/1/2020"}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA204203"], "brand_name": ["QUETIAPINE FUMARATE"], "generic_name": ["QUETIAPINE FUMARATE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6801", "0904-6802", "0904-6803", "0904-6804", "0904-6805"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["QUETIAPINE FUMARATE"], "spl_id": ["cdab9d60-c12c-474b-aa71-b7916dab8e7c"], "spl_set_id": ["b02324b1-e7f0-4cbc-8778-5f7c4a5d194a"], "package_ndc": ["0904-6801-61", "0904-6802-61", "0904-6803-61", "0904-6804-61", "0904-6805-61"], "original_packager_product_ndc": ["68180-612", "68180-613", "68180-614", "68180-615", "68180-616"], "unii": ["2S3PL1B6UJ"]}, "product_type": "Drugs", "event_id": "85138", "recalling_firm": "The Harvard Drug Group", "address_1": "17177 N Laurel Park Dr Ste 233", "address_2": "", "postal_code": "48152-3951", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1000-2020", "product_description": "Quetiapine Fumarate Extended-Release Tablets, 150 mg, 100 tablets per unit dose carton, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454775 India; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA.  NDC: 0904-6802-61", "product_quantity": "1 carton", "reason_for_recall": "Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets.", "recall_initiation_date": "20200227", "center_classification_date": "20200311", "termination_date": "20220924", "report_date": "20200318", "code_info": "Lot, expiry: Lot N00036, exp 05/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86343", "recalling_firm": "RLC Labs Inc.", "address_1": "1850 E Riverview Dr", "address_2": "N/A", "postal_code": "85034-6703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-1614-2020", "product_description": "WP Thyroid, Westhroid Pure, 1/2 Grain (32.5 mg) Thyroid USP [Liothyronine (T3) 4.5 mcg, Levothyroxine (T4) 19 mcg], packaged in a) 30-count bottles (NDC 64727-5550-4), b) 90-count bottles (NDC 64727-5550-6), c) 100-count bottles (NDC 64727-5550-1), Rx only, Manufactured by: RLC Labs Phoenix, AZ 85024", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug: FDA analysis found product to be subpotent", "recall_initiation_date": "20200825", "center_classification_date": "20200924", "termination_date": "20231108", "report_date": "20200923", "code_info": "Lot #: 119142, Exp. Date 01/2022"}, {"status": "Terminated", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85848", "recalling_firm": "Glaxosmithkline Consumer Healthcare Holdings", "address_1": "184 Liberty Corner Rd", "address_2": "N/A", "postal_code": "07059-6796", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US", "recall_number": "D-1362-2020", "product_description": "Childrens Dimetapp Cold & Cough, For ages 6 yrs. & over, 8 FL OZ. bottle, (237 mL), Distributed by: Pfizer Madison, NJ 07940, Made in Canada, UPC: 60300312234196, NDC: 0031-2234-19.", "product_quantity": "78,132 bottles", "reason_for_recall": "Defective Delivery System: the dosing cups are missing graduations applicable to certain age groups.", "recall_initiation_date": "20200616", "center_classification_date": "20200626", "termination_date": "20220603", "report_date": "20200708", "code_info": "Lot CL8292, Exp. 09/30/2021"}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85306", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Bulk product was distributed to one re-packager in California.", "recall_number": "D-1102-2020", "product_description": "LOSARTAN POTASSIUM TABLETS, USP 100 mg, Bulk, Rx only, For Further Manufacturing, Packing or Repackaging only, Manufactured by: Arrow Pharma (Malta) Ltd., Birzebbugia, Malta NDC 0591-3747-00", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.", "recall_initiation_date": "20200325", "center_classification_date": "20200407", "report_date": "20200415", "code_info": "1178533A,   1178534A,  1178535A,  1178536A,  1178537A,  1178538A,  1178539A,  1178540A,  1178541A,  1178542A,  1178543A,  1178544A,  1178545A,   1178546A exp 03/2020"}, {"status": "Terminated", "city": "Clearfield", "state": "UT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85814", "recalling_firm": "Yusef Manufacturing Laboratories, LLC", "address_1": "Freeport West, F-4, #3", "address_2": "N/A", "postal_code": "84016", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Shipped to one distributer located in Colorado", "recall_number": "D-1540-2020", "product_description": "Rocky Mountain Sunscreen SPF30 Kiwi Flavored Lip Balm (Oxybenzone 5%, Meradimate 5%, Octinoxate 7.5%, Octisalate 5%) 0.15 Oz Tube, Rocky Mtn. Sunscreen, UPC 7 54018 20004 3", "product_quantity": "2,558 pieces", "reason_for_recall": "Superpotent Drug: Active Ingredient Octisalate found at 15% above label claim.", "recall_initiation_date": "20200603", "center_classification_date": "20200824", "termination_date": "20240213", "report_date": "20200902", "code_info": "Part ID 9PRKY01, Batch #13852"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090692"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-336", "68180-337"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["1807894", "1807917"], "spl_id": ["148301d6-c0f9-4d39-9917-97b626d3048a"], "spl_set_id": ["2a84c550-aed8-4058-961f-351a5e4cf7a1"], "package_ndc": ["68180-336-07", "68180-336-02", "68180-336-01", "68180-337-07", "68180-337-01", "68180-337-02"], "is_original_packager": [true], "upc": ["0368180337072"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "85998", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-1384-2020", "product_description": "Metformin Hydrochloride Extended-Release Tablets USP 500 mg, 60 count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Manufactured by: Lupin Limited, Goa INDIA NDC 68180-336-07", "product_quantity": "59,568 bottles", "reason_for_recall": "CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level", "recall_initiation_date": "20200707", "center_classification_date": "20200714", "termination_date": "20211223", "report_date": "20200722", "code_info": "Batch #   G808293 Aug-20  G808284 Aug-20  G808285 Aug-20  G808343 Aug-20  G901201 Dec-20  G901202 Dec-20  G906915 Jul-21  G906913 Jul-21  G906914 Jul-21  G002135 Jan-22  G002849 Feb-22"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA062702"], "brand_name": ["CEPHALEXIN"], "generic_name": ["CEPHALEXIN"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-3145", "0093-3147", "0093-4175", "0093-4177"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEPHALEXIN"], "rxcui": ["309110", "309112", "309113", "309114"], "spl_id": ["c75c0bb6-fe3e-43c6-bdde-edd904731795"], "spl_set_id": ["19307ff0-71de-477b-965d-ea243e5ede3a"], "package_ndc": ["0093-3145-01", "0093-3145-05", "0093-3147-01", "0093-3147-05", "0093-4175-73", "0093-4175-74", "0093-4177-73", "0093-4177-74"], "is_original_packager": [true], "upc": ["0300934175738", "0300934177732"], "unii": ["OBN7UDS42Y"]}, "product_type": "Drugs", "event_id": "86285", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S. and Puerto Rico.", "recall_number": "D-0012-2021", "product_description": "Cephalexin for Oral Suspension, USP 125 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, a) 100 mL bottle when mixed, NDC 0093-4175-73, b) 200 mL bottle when mixed, NDC 0093-4175-74, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454.", "product_quantity": "103,940 bottles", "reason_for_recall": "CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.", "recall_initiation_date": "20200824", "center_classification_date": "20201002", "termination_date": "20211216", "report_date": "20200916", "code_info": "Lot #s: a) 30309820A, Exp. 08/2020; 30310000B, 30310001B, Exp. 10/2020; 30310096A Exp. 01/2021; 30310228A, Exp. 03/2021; 30310313A, Exp. 06/2021; b) 30309861A, Exp. 08/2020; 30310335A, Exp. 06/2021.", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84516", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Natiowide", "recall_number": "D-0644-2020", "product_description": "Glenmark Ranitidine Tablets USP 150 mg Rx Only 500 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India   Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ   NDC 68462-248-05", "product_quantity": "1,712,632 bottles", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191217", "center_classification_date": "20200105", "report_date": "20200115", "code_info": "7701034A  7701057A  7701058A  7701059A  7701060A  7701061A  7701071A  7701072A  7701073A  7701074A  7701105A  7701106A  7701107A  7701108A  7701109A  7701113A  7701114A  7701115A  7701116A  7701121A  7701122A  7701123A  7701124A  7701125A  7701126A  7701151A  7701152A  7701165A  7701154A  7701155A  7701163A  7701176A  7701190A  7701221A  7701222A  7701223A  7701224A  7701225A  7701235A  7701253A  7701254A  7701255A  7701256A  7701257A  7701258A  7701259A  7701266A  7701267A  7701268A  7701273A  7701275A  7701276A  7701277A  7701294A  7701295A  7701296A  7701297A  7701300A  7701301A  7701302A  7701303A  7701304A  7701306A  7701307A  7701308A  7701309A  7701310A  7701311A  7701312A  7701313A  7701314A  7701315A  7701316A  7701328A  7701329A  7701330A  7701331A  7701332A  7701333A  7701344A  7701153A  7701175A  7701234A  7701274A  7701305A  7701345A  7701352A  7701353A  7701354A  7701355A  7701356A  7701382A  7701383A  7701384A  7701385A  7701402A  7701403A  7701404A  7701405A  7701419A  7701420A  7701422A  7701423A  7701424A  7701425A  7701426A  7701427A  7701430A  7701432A  7701433A  7701448A  7701449A  7701450A  7701451A  7701454A  7701455A  7701471B  7701557A  7701558A  7701559A  7701583A  7701584A  7701585A  7701586A  7701587A  7701588A  7701614A  7701615A  7701616A  7701621A  7701637A  7701638A  7701639A  7701652A  7701653A  7701654A  7701655A  7701656A  7701657A  7701658A  7701664A  7701665A  7701666A  7701667A  7701668A  7701669A  7701670A  7701680A  7701613A  7701699A  7701700A  7701701A  7701714A  7701715A  7701716A  7701717A  7701718A  7701719A  7701720A  7701721A  7701781A  7701782A  7701783A  7701784A  7701796A  7701926A  7701927A  7701937A  7701938A  7701939A  7701940A  7701941A  7702004A  7702005A  7702006A  7702007A  7702008A  7702009A  7702010A  7702011A  7702013A  7702014A  7702068A  7702222A  7702223A  7702224A  7702230A  7702231A  7702232A  7702233A  7702242B  7702243A  7702244A  7702245A  7702246A  7702247A  7702248A  7702249A  7702250A  7702251A  7702252A  7702291A  7702292A  7702293A  7702302A  7702303A  7702304A  7702305A  7702306A  7702307A  7702308A  7702309A  7702331A  7702332A  7702333A  7702334A  7702339A  7702340A  7702346A  7702353A  7702354A  7702355A  7702356A  7702376A  7702377A  7702378A  7702379A  7702390A  7702310A  7702411A  7702412A  7702490A  7702493A  7702494A  7702498A  7702499A  7702500A  7702501A  7702502A  7702503A  7702516A  7702517A  7702518A  7702519A  7702549A  7702550A  7702551A  7702552A  7702601A  7702602A  7702603A  7702604A  7702605A  7702606A  7702607A  7702608A  7702621A  7702622A  7702623A  7702655A  7702656A  7702657A  7702658A  7702741A  7702742A  7702743A  7702765A  7702766A  7702777A  7702778A  7702779A  7702780A  7702781A  7702782A  7702783A  7702784A  7702794A  7702795A  7702796A  7702797A  7702811A  7702812A  7702813A  7702814A  7702815A  7702816A  7702817A  7702818A  7702819A  7702820A  7702821A  7702822A  7702848A  7702849A  7702850A  7702856A  7702857A  7702861A  7702896A  7702897A  7702898A  7702899A  7702910A  7702911A  7702912A  7702913A  7702914A  7702915A  7702916A  7702924A  7702925A  7702926A  7702927A  7703060A  7703061A  7703062A  7703063A  7703064A  7703065A  7703066A  7703067A  7703068A  7703144A  7703145A  7703146A  7703147A  7703174A  7703175A  7703176A  7703177A  7703178A  7703179A  7703180A  7703181A  7703182A  7703183A  7703191A  7703192A  7703193A  7703194A  7703195A  7703236A  7703237A  7703238A  7703239A  7703240A  7703248A  7703249A  7703250A  7703251A  7703252A  7703253A  7703254A  7703255A  7703283A  7703284A  7703290A  7703291A  7703292A  7703293A  7703294A  7703295A  7703296A  7703318A  7703330A  7703331A  7703332A  7703333A  7703334A  7703347A  7703348A  7703349A  7703350A  7703351A  7703394A  7703395A  7703409A  7703491A  7703492A  7703493A  7703494A  7703495A  7703496A  7703497A  7703498A  7703499A  7703500A  7703501A  7703502A  7703503A  7703504A  7703635A  7703636A  7703637A  7703638A  7703775A  7703776A  7703777A  7703778A  7703779A  7703780A  7703781A  7703782A  7703783A  7703925A  7703926A  7703934A  7703935A  7703936A  7703937A  7703938A  7703939A  7703970A  7703971A  7703972A  7704003A  7704004A  7704098A  7704099A  7704100A  7704101A  7704102A  7704103A  7704104A  7704181A  7704182A  7704183A  7704184A  7704185A  7704186A  7704187A  7704188A  7704189A  7704190A  7704191A  7704192A  7704193A  7704297A  7704298A  7704299A  7704300A  7704301A  7704302A  7704327A  7704328A  7704329A  7704330A  7704331A  7704332A  7704333A  7704334A  7704408A  7704409A  7704410A  7704411A  7704412A  7704413A  7704419A  7704420A  7704421A  7704422A  7704423A  7704424A  7704425A  7704496A  7704497A  7704502A  7704503A  7704504A  7704505A  7704506A  7704507A  7704559A  7704560A  7704561A  7704562A  7704574A  7704575A  7704606A  7704607A  7704608A  7704649A  7704650A  7704651A  7704652A  7704653A  7704654A  7704655A  7704656A  7704657A  7704658A  7704659A  7704673A  7704674A  7704675A  7704676A  7704677A  7704678A  7704679A  7704735A  7704736A  7704737A  7704738A  7704739A  7704810A  7704811A  7704812A  7704834A  7704835A  7704836A  7704837A  7704856A  7704857A  7704948A  7704949A  7704950A  7704951A  7704971A  7704972A  7704973A  7704974A  7704975A  7704976A  7704977A  7704980A  7704981A  7704982A  7704983A  7704984A  7704985A  7705014A  7705049A  7705125A  7705126A  7705127A  7705128A  7705129A  7705130A  7705131A  7705132A  7705133A  7705134A  7705135A  7705136A  7705137A  7705138A  7705150A  7705151A  7705152A  7705153A  7705382A  7705383A  7705386A  7705388A  7705391A  7705566A  7705568A  7705569A  7705589A  7705591A  7705595A  7705596A  7705597A  7705598A  7705599A  7705600A  7705601A  7705614A  7705615A  7705618A  7705619A  7705620A  7705621A  7705622A  7705623A  7705624A  7705387A  7705389A  7705390A  7705592A  7705593A  7705594A  7705602A  7705616A  7705617A  19190289  19190342  19190372  19190385  19191898  19192447  19192461  19192468  19192481  7702624A  7702625A  7702738A  7702739A  7702740A  7704858A  7704859A  7704860A  7704861A  7704892A  7704893A  7704894A  7704895A  7704896A  7704912A  7704926A  7704927A  7704928A  7704929A  7704930A  7704931A  7704932A"}, {"status": "Terminated", "city": "Seattle", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85706", "recalling_firm": "BIOTA Biosciences LLC", "address_1": "1601 5th Ave Ste 1100", "address_2": "N/A", "postal_code": "98101-3603", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States and New Zealand", "recall_number": "D-1327-2020", "product_description": "Sterile Curcumin, 4mg/mL, 10mL vial", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin", "recall_initiation_date": "20200511", "center_classification_date": "20200619", "termination_date": "20201203", "report_date": "20200701", "code_info": "Lot #: 2H071219CCD, 2H0712019CCD, 2H07122019CCD, Exp. Date 7/12/2021"}, {"status": "Terminated", "city": "Hastings", "state": "NE", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85081", "recalling_firm": "Redline Pharmacy Solutions", "address_1": "2415 Osborne Dr E Ste 100", "address_2": "", "postal_code": "68901-1999", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Sold to patients in Nebraska", "recall_number": "D-1011-2020", "product_description": "Morphine Sulfate (MITIGO), 5 mg/mL intrathecal, 40 mL per syringe. Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901", "product_quantity": "1 40 ml syringe", "reason_for_recall": "Lack Of Processing Controls", "recall_initiation_date": "20200224", "center_classification_date": "20200312", "termination_date": "20220331", "report_date": "20200318", "code_info": "Lot 02242020@14", "more_code_info": ""}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1193-2020", "product_description": "Bi-Est (8:2)/DHEA/Testosterone 0.8 mg/ 9/0.4 mg/0.2 mg/mL Cream 6 gm tube, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 tube", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 44798 Discard by: 5/22/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0692-2020", "product_description": "BUP 20MG/CLON 300MCG/FENT 2000MCG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@28 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86193", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S.", "recall_number": "D-1550-2020", "product_description": "Heparin Sodium 2,500 units in 0.9% Sodium Chloride 500 mL, Single Dose Container, Rx Only Injection for Intravenous Use (5 units/mL), SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC#: 70004-0655-44, Bar Code 70004065544.", "product_quantity": "1,097 Containers", "reason_for_recall": "Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.", "recall_initiation_date": "20200729", "center_classification_date": "20200827", "termination_date": "20210521", "report_date": "20200902", "code_info": "Lot #: 1220019269, 1220019278, Exp 08/21/2020; 1220019386, Exp 08/25/2020."}, {"status": "Terminated", "city": "East Haven", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86579", "recalling_firm": "Milbar Laboratories, Inc.", "address_1": "20 Commerce St", "address_2": "N/A", "postal_code": "06512-4145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States, including Puerto Rico and internationally.", "recall_number": "D-0095-2021", "product_description": "DCL Clear Skin Anti-Blemish Hydrator (2% Salicylic Acid), 50ml/1.7 fl. oz, Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA", "product_quantity": "927 tubes", "reason_for_recall": "GMP Deviations", "recall_initiation_date": "20201009", "center_classification_date": "20201117", "termination_date": "20230104", "report_date": "20201125", "code_info": "Lot #: FX432-5, Exp. Date June-21"}, {"status": "Completed", "city": "Jenison", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85854", "recalling_firm": "MICHIGAN HERBAL REMEDIES", "address_1": "904 Chicago Dr", "address_2": "", "postal_code": "49428-9351", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide via internet sales,retailers and distributors in the USA", "recall_number": "D-1454-2020", "product_description": "A Clean Choice CBD, Hemp Oil Extract Tincture, French Vanilla, 1000 mg, 1 fl oz (30 ml) bottles, Made in Michigan for A Clean Choice, A Division of A Clean Cigarette, Inc., 3055 Bay Road Suite 1, Saginaw, MI 48603", "product_quantity": "350 bottles", "reason_for_recall": "Chemical contamination: product contains elevated levels of undeclared lead.", "recall_initiation_date": "20200618", "center_classification_date": "20200804", "report_date": "20200812", "code_info": "FG003106", "more_code_info": ""}, {"status": "Terminated", "city": "Cherry Hill", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075772"], "brand_name": ["KETOROLAC TROMETHAMINE"], "generic_name": ["KETOROLAC TROMETHAMINE"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0641-6041", "0641-6043", "0641-6042"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["KETOROLAC TROMETHAMINE"], "rxcui": ["860092", "1665459", "1665461"], "spl_id": ["25d6c438-45d2-4162-91c2-b5caa0f86bf3"], "spl_set_id": ["0c2c75c9-ed7b-46a8-9543-429bf2d8f090"], "package_ndc": ["0641-6043-01", "0641-6043-25", "0641-6042-01", "0641-6042-25", "0641-6041-01", "0641-6041-25"], "is_original_packager": [true], "unii": ["4EVE5946BQ"]}, "product_type": "Drugs", "event_id": "84534", "recalling_firm": "Hikma Pharmaceuticals USA Inc.", "address_1": "2 Esterbrook Ln", "address_2": "", "postal_code": "08003-4002", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0658-2020", "product_description": "Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL Single Dose Vials (NDC 0641-6043-01), 25 vials/shelf-pack (NDC 0641-6043-25), For IM Use Only, Rx only, Manufactured by: WEST-WARD Eatontown, NJ 07724 USA.", "product_quantity": "25,817 shelf packs/25 vials per pack", "reason_for_recall": "Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS)", "recall_initiation_date": "20191217", "center_classification_date": "20200302", "termination_date": "20210609", "report_date": "20200122", "code_info": "038368,  Exp. Mar 2020; 058314, Exp. May 2020; 078305,  078307, Exp. July 2020; 118362 Exp. Nov 2020", "more_code_info": ""}, {"status": "Ongoing", "city": "San Juan Del Rio", "state": "N/A", "country": "Mexico", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86162", "recalling_firm": "Albek De Mexico S.A. De C.V.", "address_1": "Oriente Cuatro No. 11 Nuevo", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0079-2021", "product_description": "Modesa INSTANT HAND SANITIZER with Moisturizers and Aloe Vera (ethyl alcohol 70% v/v) 8 fl oz (237 mL) bottle, Distributed by: Midwood brands, LLC 10611 Monroe RD. Mathews, NC 28105 Made in Mexico UPC 3 2251 38042 6", "product_quantity": "2,760 bottles", "reason_for_recall": "CGMP Deviations: Next Advanced Antibacterial Hand Sanitizer was found to be below the label claim for ethanol content and contained methanol. Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.", "recall_initiation_date": "20200730", "center_classification_date": "20201117", "report_date": "20201125", "code_info": "1931104AL"}, {"status": "Terminated", "city": "South Richmond Hill", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85992", "recalling_firm": "MasterPharm LLC", "address_1": "11502 Liberty Ave Fl 2", "address_2": "N/A", "postal_code": "11419-1902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1422-2020", "product_description": "Finasteride Plus 1.25mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600", "product_quantity": "29580 capsules", "reason_for_recall": "Lack of Processing Controls (lack of assurance of conformity to specifications).", "recall_initiation_date": "20200702", "center_classification_date": "20200729", "termination_date": "20240223", "report_date": "20200805", "code_info": "01-07-2020:64@5, BUD 7/5/2020  01-13-2020:12@26, BUD 7/11/2020  01-30-2020:39@8, BUD 7/28/2020  02-14-2020:10@8, BUD 8/12/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0677-2020", "product_description": "Bi-Mix 30 mg/1 mg/mL Inj. in 1 mL vials Assurance Infusion (713) 533-8800", "product_quantity": "15 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 09192019@19 Exp. 03/17/2020; 08162019@5 Exp. 02/12/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1146-2020", "product_description": "New Life, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Cherry Hill", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201833"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0641-0497", "0641-6144"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807636", "1807637"], "spl_id": ["0950e98d-bfec-40e8-9f56-ba90e0d6e8c8"], "spl_set_id": ["e5ee8caa-b6ca-45ba-98fb-8305e6282141"], "package_ndc": ["0641-0497-17", "0641-0497-25", "0641-6144-01", "0641-6144-25"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "86685", "recalling_firm": "Hikma Pharmaceuticals USA Inc.", "address_1": "2 Esterbrook Ln", "address_2": "N/A", "postal_code": "08003-4002", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0101-2021", "product_description": "Sodium Chloride Injection, USP, 0.9%, 0.308 mOsmol/mL, 2mL Single Dose Vial, Preservative Free, For use as a sterile diluent, Rx Only, Mfd. by. West-ward Eatontown, NJ 07724 USA, a) Vial NDC 0641-0497-17, b) Carton of 25 vials NDC 0641-0497-25.", "product_quantity": "2,100,646 Vials", "reason_for_recall": "Failed pH Specifications: Out of Specification pH Test Results were found in Sodium Chloride Injection USP 0.9% 2 mL vial.", "recall_initiation_date": "20201103", "center_classification_date": "20201120", "termination_date": "20221117", "report_date": "20201125", "code_info": "a) Vial Lot #s: 078338 Exp. 7/2021; Lot 088391, Exp. 08/2021; 098340, Exp. 09/2021; 108325 Exp. 10/2021; 010018 Exp. 1/2023; b) Carton Lot #: 068322, Exp. 06/2021."}, {"status": "Terminated", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86695", "recalling_firm": "AVKARE Inc.", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0070-2021", "product_description": "Mesalamine Delayed-Release Tablets, USP 1.2 gram (Once-Daily), 120 Tablets bottle, Rx Only Manufactured for: AvKARE, Inc. Pulaski, TN 38478  NDC 42291-564-12", "product_quantity": "15,678 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20201030", "center_classification_date": "20201106", "termination_date": "20230602", "report_date": "20201118", "code_info": "Lots: 26085 Exp. 07/2021, 26426 Exp. 01/2022, 26983 Exp. 04/2022, 28647 Exp. 06/2022", "more_code_info": ""}, {"status": "Terminated", "city": "South Richmond Hill", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85992", "recalling_firm": "MasterPharm LLC", "address_1": "11502 Liberty Ave Fl 2", "address_2": "N/A", "postal_code": "11419-1902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1433-2020", "product_description": "Progesterone Modified Release 100 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600", "product_quantity": "600 capsules", "reason_for_recall": "Lack of Processing Controls (lack of assurance of conformity to specifications).", "recall_initiation_date": "20200702", "center_classification_date": "20200729", "termination_date": "20240223", "report_date": "20200805", "code_info": "02-12-2020:13@5, BUD 8/10/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0697-2020", "product_description": "BUP 2MG/ HYDROM 2MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@10 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86343", "recalling_firm": "RLC Labs Inc.", "address_1": "1850 E Riverview Dr", "address_2": "N/A", "postal_code": "85034-6703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-1600-2020", "product_description": "Nature-Throid, Thyroid USP [liothyronine (T3) 13.5 mcg and levothyroxine (T4) 57 mcg], 1.5 Grain (97.5 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3305-4; b) 60-count bottles, NDC 64727-3305-5; c) 90-count bottles, NDC 64727-3305-6; d) 100-count bottles,  NDC 64727-3305-1; and e) 1,000-count bottles, NDC 64727-3305-2; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: manufactured under the same conditions as those found to be subpotent.", "recall_initiation_date": "20200825", "center_classification_date": "20200924", "termination_date": "20231108", "report_date": "20200923", "code_info": "All lots with expiry between 10/2020-07/2023"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0723-2020", "product_description": "CLON 500MCG/HYDROM 5MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@22 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Lewes", "state": "DE", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85944", "recalling_firm": "POLARIZED LLC", "address_1": "16192 Coastal Hwy", "address_2": "N/A", "postal_code": "19958-3608", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed in VA with potential for Nationwide distribution in USA", "recall_number": "D-1412-2020", "product_description": "Saniderm ADVANCED HAND SANITIZER, 70% Alcohol Content, 1 Liter bottles, Distributed by Polarized, LLC, Produced by Eskbiochem SA de CV, Mexico Japon 50, Celaya, Gto., Mexico, 38010. UPC 8 60003 63391 5.", "product_quantity": "18, 126 bottles", "reason_for_recall": "CGMP Deviations: Product was found to be below the label claim for ethanol content and the presence of undeclared methanol.", "recall_initiation_date": "20200625", "center_classification_date": "20200728", "termination_date": "20201202", "report_date": "20200805", "code_info": "Lot # all lots to include 53131626"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0933-2020", "product_description": "Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection, 40 mcg/25 mg/0.5mg/0.01mg/ml, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0549-2", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 12042019+533225, Exp 1/17/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0698-2020", "product_description": "BUP 3.5MG/ HYDROM 4MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@27 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1160-2020", "product_description": "Skin Lift Balm, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0663-2020", "product_description": "Autologous Serum 20% Eye Drops in 3 mL droppers Assurance Infusion (713) 533-8800", "product_quantity": "32 droppers", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12092019@33 Exp. 03/08/2020; 11112019@30 Exp. 02/09/2020; 10012019@17 Exp. 12/30/2019; 10162019@18 Exp. 01/14/2020; 10252019@11 Exp. 01/23/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86982", "recalling_firm": "SCA Pharmaceuticals, Inc.", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0171-2021", "product_description": "Vasopressin 20 Units added to 0.9% Sodium Chloride 100 mL Rx Only, Single Dose Container, SCA Pharmaceuticals 8821 Knoedl Ct. Little Rock, AR 72205 Bar Code 70004093232", "product_quantity": "654 bags", "reason_for_recall": "Subpotent drug.", "recall_initiation_date": "20201214", "center_classification_date": "20201221", "termination_date": "20210923", "report_date": "20201230", "code_info": "Lots: 1120025012 BUD: 01/13/2021, 1120025015 BUD: 01/15/2021, 1120025272 BUD: 01/28/2021"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0948-2020", "product_description": "Cyanocobalamin Injection, CYANOCOBALAMIN   2000 MCG/ML INJECTABLE, For IV, IM, SC Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0330-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #:07172019+52695, 07172019+52697, 07252019+52759, Exp 1/25/2020"}, {"status": "Terminated", "city": "Tajpura", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA202101"], "brand_name": ["ARIPIPRAZOLE"], "generic_name": ["ARIPIPRAZOLE"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "product_ndc": ["62332-097", "62332-098", "62332-099", "62332-100", "62332-101", "62332-102"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ARIPIPRAZOLE"], "rxcui": ["349490", "349545", "349547", "349553", "402131", "602964"], "spl_id": ["27cb5061-f64f-4328-9d1e-c18250dcb23a"], "spl_set_id": ["a10a5427-58b1-42dd-964c-3f8c78770534"], "package_ndc": ["62332-097-30", "62332-097-71", "62332-097-91", "62332-097-31", "62332-097-10", "62332-098-30", "62332-098-31", "62332-098-91", "62332-098-10", "62332-098-71", "62332-099-30", "62332-099-31", "62332-099-71", "62332-099-91", "62332-099-10", "62332-100-30", "62332-100-31", "62332-100-71", "62332-100-91", "62332-100-10", "62332-101-30", "62332-101-31", "62332-101-71", "62332-101-91", "62332-101-10", "62332-102-30", "62332-102-31", "62332-102-71", "62332-102-91", "62332-102-10", "1905003298"], "is_original_packager": [true], "upc": ["0362332097302"], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["82VFR53I78"]}, "product_type": "Drugs", "event_id": "85835", "recalling_firm": "Alembic Pharmaceuticals Limited", "address_1": "Near Baska", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1341-2020", "product_description": "Aripiprazole Tablets, USP, 2 mg, 30 Tablets per bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division) Panelav 389350, Gujarat, India  Manufactured for: Alembic Pharmaceuticals, Inc. 750 Route 202, Bridgewater, NJ 08807 USA, NDC 62332-097-30.", "product_quantity": "19,153 bottles", "reason_for_recall": "Labeling: Label mix up: Bottles labeled as aripiprazole 2 mg, 30 count had aripiprazole 5 mg tablets, 100 count.", "recall_initiation_date": "20200610", "center_classification_date": "20200624", "termination_date": "20220119", "report_date": "20200701", "code_info": "Lot: 1905003298 Exp. 01/31/2021"}, {"status": "Terminated", "city": "East Haven", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86579", "recalling_firm": "Milbar Laboratories, Inc.", "address_1": "20 Commerce St", "address_2": "N/A", "postal_code": "06512-4145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States, including Puerto Rico and internationally.", "recall_number": "D-0094-2021", "product_description": "DCL Alpha Beta Gel Toner (1.95% Salicylic Acid) 200 mL/6.7 fl. oz, Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA", "product_quantity": "2,335 bottles", "reason_for_recall": "GMP Deviations", "recall_initiation_date": "20201009", "center_classification_date": "20201117", "termination_date": "20230104", "report_date": "20201125", "code_info": "Lot # HV093-6, exp. date Aug-21"}, {"status": "Terminated", "city": "Baudette", "state": "MN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA205401"], "brand_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "product_ndc": ["43975-277", "43975-278", "43975-279", "43975-280", "43975-282", "43975-281"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMPHETAMINE DL-ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "rxcui": ["861221", "861223", "861225", "861227", "861232", "861237"], "spl_id": ["d0db10e9-cc85-492d-9f29-663948539b07"], "spl_set_id": ["6438480f-1147-42b6-826d-4e1e1f8ff007"], "package_ndc": ["43975-277-10", "43975-278-10", "43975-279-10", "43975-280-10", "43975-282-10", "43975-281-10"], "is_original_packager": [true], "upc": ["0343975282102", "0343975281105", "0343975278105", "0343975280108", "0343975277108", "0343975279102"], "unii": ["O1ZPV620O4", "G83415V073", "JJ768O327N", "6DPV8NK46S"]}, "product_type": "Drugs", "event_id": "86584", "recalling_firm": "ANI Pharmaceuticals, Inc.", "address_1": "455 Idc Rd Sw", "address_2": "N/A", "postal_code": "56623-2467", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0048-2021", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 30 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-282-10", "product_quantity": "34968 bottles", "reason_for_recall": "Labeling: Incorrect expiration date.  Product dated with 24-month expiration date instead of 18-months.", "recall_initiation_date": "20201009", "center_classification_date": "20201021", "termination_date": "20220119", "report_date": "20201028", "code_info": "Lot: 19T17 Exp. Dec. 2021, 19T18, 19T19, Exp. Jan. 2022; 20D05 Exp. Apr. 2022; 20D21, Exp. May 2022"}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "84620", "recalling_firm": "Idelle Labs", "address_1": "One Helen Of Troy Plaza", "address_2": "N/A", "postal_code": "79912", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0785-2020", "product_description": "SURE 48hr Confidence Regular Original Solid Anti-Perspirant & Deodorant Net Wt 2.7 oz (76g) NDC# 41595-5514-1 UPC 8 83484 717936 6 Made in Canada and Distributed by Idelle Labs, Ltd., El Paso, TX 79912", "product_quantity": "Unknown", "reason_for_recall": "Labeling Product Contains Undeclared API: Active Ingredient on label is not the active ingredient in the product.", "recall_initiation_date": "20191120", "center_classification_date": "20200116", "termination_date": "20220928", "report_date": "20200115", "code_info": "Lots: 19279K1, 19279K2, 19280K1"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0961-2020", "product_description": "Levocarnitine Injection, LEVOCARNITINE  500 MG/ML INJECTABLE, For IV Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-9260-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 08212019+52824, Exp 2/17/2020"}, {"status": "Terminated", "city": "East Haven", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86579", "recalling_firm": "Milbar Laboratories, Inc.", "address_1": "20 Commerce St", "address_2": "N/A", "postal_code": "06512-4145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States, including Puerto Rico and internationally.", "recall_number": "D-0085-2021", "product_description": "DCL AHA Lightening Gel (hydroquinone 2%), 30 ml/1 fl.oz. Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA, UPC 357486500471", "product_quantity": "1,608 bottles", "reason_for_recall": "GMP Deviations", "recall_initiation_date": "20201009", "center_classification_date": "20201117", "termination_date": "20230104", "report_date": "20201125", "code_info": "Lot #: LW110-3, Exp. Date Nov-22"}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1226-2020", "product_description": "Ergotamine Tartrate 1 mg/Caffeine 100 mg base F Suppository (Pink) 48 suppositories, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "2 boxes", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45247 Discard by: 9/19/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203817"], "brand_name": ["MESALAMINE"], "generic_name": ["MESALAMINE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-2245"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MESALAMINE"], "rxcui": ["686429"], "spl_id": ["1300887a-c110-46b3-a8be-cfceabf0cbf2"], "spl_set_id": ["ba1e3bd4-fbe0-46a5-961e-167ccb09672c"], "package_ndc": ["0591-2245-22"], "is_original_packager": [true], "upc": ["0305912245229"], "nui": ["N0000175781", "M0000971"], "pharm_class_epc": ["Aminosalicylate [EPC]"], "pharm_class_cs": ["Aminosalicylic Acids [CS]"], "unii": ["4Q81I59GXC"]}, "product_type": "Drugs", "event_id": "86667", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S. and PR", "recall_number": "D-0069-2021", "product_description": "Mesalamine Delayed-Release Tablets, USP 1.2 gram, 120 tablets per bottle, Rx Only, Manufactured by: Actavis Laboratories, FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma Inc., Parsippany, NJ 07054, NDC 0591-2245-22.", "product_quantity": "133,829 bottles", "reason_for_recall": "Failed Dissolution Specifications: Out-of-specification dissolution results were obtained during stability testing.", "recall_initiation_date": "20201028", "center_classification_date": "20201106", "termination_date": "20210826", "report_date": "20201118", "code_info": "Lot #s: 1342498A, Exp. 12/2020; 1342499A, Exp. 01/2021; 1354638A, Exp. 03/2021; 1354639A, 1358274A, 1358448A, 1364618A, 1369884A, Exp. 05/2021; 1366195A, 1369885A, 1373570A, Exp. 06/2021; 1373571A, Exp. 07/2021; 1388571A, Exp. 01/2022; 1395725A, 1396585A, 1397550A, 1399389A, Exp. 04/2022; 1403885A, 1403886A, Exp. 06/2022.", "more_code_info": ""}, {"status": "Terminated", "city": "Seattle", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85706", "recalling_firm": "BIOTA Biosciences LLC", "address_1": "1601 5th Ave Ste 1100", "address_2": "N/A", "postal_code": "98101-3603", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States and New Zealand", "recall_number": "D-1326-2020", "product_description": "Sterile Cannabidiol (CBD) 4mg/mL, 10mL vial", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin", "recall_initiation_date": "20200511", "center_classification_date": "20200619", "termination_date": "20201203", "report_date": "20200701", "code_info": "Lot #: 2H071219P, 2H0712019P,  2H07122019P, Exp. Date 7/12/2021"}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1195-2020", "product_description": "Ergotamine Tartrate 1 mg/Caffeine 100 mg Base Suppository (Pink) 48 count box, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 box", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45247 Discard by: 9/19/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0722-2020", "product_description": "CLON 300MCG/MORP 10MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12132019@8 Exp. 12/22/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86343", "recalling_firm": "RLC Labs Inc.", "address_1": "1850 E Riverview Dr", "address_2": "N/A", "postal_code": "85034-6703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-1606-2020", "product_description": "WP Thyroid, Westhroid Pure, Thyroid USP, [liothyronine (T3) 2.25 mcg and levothyroxine (T4) 9.5 mcg], 1/4 Grain (16.25 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-5450-4; b) 60-count bottles, NDC 64727-5450-5; c) 90-count bottles, NDC 64727-5450-6; d) 100-count bottles, NDC 64727-5450-1; and e) 1,000-count bottles, NDC 64727-5450-2; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: manufactured under the same conditions as those found to be subpotent.", "recall_initiation_date": "20200825", "center_classification_date": "20200924", "termination_date": "20231108", "report_date": "20200923", "code_info": "All lots with expiry between 10/2020-07/2023"}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83645", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "PA", "recall_number": "D-1030-2020", "product_description": "Lisinopril/HCTZ 20mg/12.5mg Tablet, QTY: 30 tablets per blister card, MFG: Lupin Pharma Baltimore, MD 21202, NDC 68180-0519-02 (Original NDC of 500 count bottle); 70518-0382-03 (Repackaged NDC for blister cards).", "product_quantity": "480 tablets", "reason_for_recall": "Presence of Foreign Tablets/Capsules: This is a spin-off recall of D-1581-2019 due to a product complaint where one of Lupin's Fenofibrate 145mg was observed in the 500 s count product bottle.", "recall_initiation_date": "20190805", "center_classification_date": "20200316", "termination_date": "20230602", "report_date": "20200325", "code_info": "Lot #: J0322819-091418, Exp: 09/30/2019", "more_code_info": ""}, {"status": "Ongoing", "city": "San Juan Del Rio", "state": "N/A", "country": "Mexico", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86162", "recalling_firm": "Albek De Mexico S.A. De C.V.", "address_1": "Oriente Cuatro No. 11 Nuevo", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0078-2021", "product_description": "NuuxSan Instant ANTIBACTERIAL HAND SANITIZER, 70% Ethyl Alcohol (ethyl alcohol 70%), 8 fl oz. 237 mL bottle, Distributed by PCM North America LLC 9543 Bassonnet ST. STE 307, Houston, TX 77036, Made in Mexico, UPC 7 13620 00017 5", "product_quantity": "1,441,548 bottles", "reason_for_recall": "CGMP Deviations: Next Advanced Antibacterial Hand Sanitizer was found to be below the label claim for ethanol content and contained methanol. Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.", "recall_initiation_date": "20200730", "center_classification_date": "20201117", "report_date": "20201125", "code_info": "all lots"}, {"status": "Terminated", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M016"], "brand_name": ["CHAPSTICK TOTAL HYDRATION MOISTURE TINT PRETTY IN PINK"], "generic_name": ["ZINC OXIDE"], "manufacturer_name": ["Haleon US Holdings LLC"], "product_ndc": ["0573-0873"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ZINC OXIDE"], "spl_id": ["e52d49cf-7641-4a10-adab-79ee29da23db"], "spl_set_id": ["e686ce23-57bc-4026-be62-d46d90ded442"], "package_ndc": ["0573-0873-08", "0573-0873-11"], "is_original_packager": [true], "unii": ["SOI2LOH54Z"]}, "product_type": "Drugs", "event_id": "85500", "recalling_firm": "Glaxosmithkline Consumer Healthcare Holdings", "address_1": "184 Liberty Corner Rd", "address_2": "N/A", "postal_code": "07059-6796", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1268-2020", "product_description": "ChapStick Total Hydration Moisture + Tint + SPF15 Pretty in Pink Net Wt. 0.08 OZ (2.2g) Marketed by: Pfizer, Madison, NJ 07940 USA NDC 0573-0873-08", "product_quantity": "360 packages", "reason_for_recall": "Labeling: Not elsewhere classified: Observed separation in the secondary packaging in the blister and the backer card", "recall_initiation_date": "20200420", "center_classification_date": "20200513", "termination_date": "20211026", "report_date": "20200520", "code_info": "Lot #: 9343AA, 9343BA"}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202800"], "brand_name": ["ACETAMINOPHEN AND CODEINE PHOSPHATE"], "generic_name": ["ACETAMINOPHEN AND CODEINE PHOSPHATE"], "manufacturer_name": ["Aurolife Pharma, LLC"], "product_ndc": ["13107-058", "13107-059", "13107-060"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN", "CODEINE PHOSPHATE"], "rxcui": ["993770", "993781", "993890"], "spl_id": ["4c82ae3f-5e61-4b95-821f-1e9a1775682e"], "spl_set_id": ["02386806-02d4-47e3-9c8b-7810146ee795"], "package_ndc": ["13107-058-30", "13107-058-01", "13107-058-05", "13107-058-99", "13107-059-30", "13107-059-01", "13107-059-05", "13107-059-99", "13107-060-30", "13107-060-01", "13107-060-05", "13107-060-99"], "is_original_packager": [true], "unii": ["362O9ITL9D", "GSL05Y1MN6"]}, "product_type": "Drugs", "event_id": "85183", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1231-2020", "product_description": "Acetaminophen and Codeine Phosphate Tablets, USP, 300 mg/60 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ 08810, NDC 13107-060-01", "product_quantity": "57337 units", "reason_for_recall": "CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed", "recall_initiation_date": "20200318", "center_classification_date": "20200413", "termination_date": "20240325", "report_date": "20200422", "code_info": "Lot #:  060180017A, 060180019B1, 060180020A and 060180021A, Exp. Date 06/2021", "more_code_info": ""}, {"status": "Completed", "city": "Florham Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86805", "recalling_firm": "BASF Corporation", "address_1": "100 Park Ave", "address_2": "N/A", "postal_code": "07932-1049", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "USA Nationwide and Worldwide", "recall_number": "D-0149-2021", "product_description": "Kollidon CL-M Crospovidone Ph.Eur.Type B, USP/NF, JP, micronized, packaged in 30 kg plastic drums, Manufacturer: BASF SE, Carl-Bosch-Strabe 38, 67056 Ludwigshafen, Germany, Co-Manufactured by Siegfried PharmaChemikalien Minden GmbH, D-32423 Minden", "product_quantity": "4560 kg", "reason_for_recall": "Cross contamination: the excipient was found to be contaminated with theophylline.", "recall_initiation_date": "20201117", "center_classification_date": "20201215", "report_date": "20201223", "code_info": "Batch # 18472036, 18472041."}, {"status": "Terminated", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA091657"], "brand_name": ["TRANEXAMIC ACID"], "generic_name": ["TRANEXAMIC ACID"], "manufacturer_name": ["Mylan Institutional LLC"], "product_ndc": ["67457-197"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["TRANEXAMIC ACID"], "rxcui": ["238720"], "spl_id": ["8b527f21-61b4-4707-8ea5-629f47f707e2"], "spl_set_id": ["6f033f1e-8c78-4c87-b870-6493944315ff"], "package_ndc": ["67457-197-00", "67457-197-10"], "is_original_packager": [true], "nui": ["N0000175634", "N0000175632"], "pharm_class_epc": ["Antifibrinolytic Agent [EPC]"], "pharm_class_pe": ["Decreased Fibrinolysis [PE]"], "unii": ["6T84R30KC1"]}, "product_type": "Drugs", "event_id": "86247", "recalling_firm": "Mylan Institutional LLC", "address_1": "4901 Hiawatha Dr", "address_2": "N/A", "postal_code": "61103-1287", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1576-2020", "product_description": "Tranexamic Acid Injection, USP, 1000 mg/10 mL (100 mg/mL), 10 mL Single-Dose Vial (NDC 67457-197-00); 10 x 10 mL Single-Dose Vials per carton (NDC 67457-197-10), Rx only, Manufactured by: Mylan Institutional, Galway, Ireland; Manufactured for: Mylan Institutional LLC, Rockford, IL  61103.", "product_quantity": "1407 cartons", "reason_for_recall": "Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.", "recall_initiation_date": "20200817", "center_classification_date": "20200911", "termination_date": "20221228", "report_date": "20200909", "code_info": "Lot #: 191207, 191221, 191223,  Exp. 11/2021; 200120 Exp. 12/2021"}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84857", "recalling_firm": "Contract Pharmacal Corporation", "address_1": "135 Adams Ave", "address_2": "", "postal_code": "11788-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0857-2020", "product_description": "Leader Extra Strength Acetaminophen Tablets, 500 mg Pain Reliever/Fever Reducer,100-count bottles,Distributed by Cardinal Health, Dublin OHIO 43017 NDC 7000-0036-1, UPC 0 96295 13807 8", "product_quantity": "5472 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.", "recall_initiation_date": "20200203", "center_classification_date": "20200227", "termination_date": "20240422", "report_date": "20200219", "code_info": "Lot #: 193005, Exp. Date 08/21", "more_code_info": ""}, {"status": "Completed", "city": "Jenison", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85854", "recalling_firm": "MICHIGAN HERBAL REMEDIES", "address_1": "904 Chicago Dr", "address_2": "", "postal_code": "49428-9351", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide via internet sales,retailers and distributors in the USA", "recall_number": "D-1468-2020", "product_description": "Acadia Farms, Equilibrium, vermont maple, 300 MG Hemp Oil, 1 Fl OZ (30 ML) bottles, Distributed by: Acadia Farms, Rehobeth, Massachusetts", "product_quantity": "100 bottles", "reason_for_recall": "Chemical contamination: product contains elevated levels of undeclared lead.", "recall_initiation_date": "20200618", "center_classification_date": "20200804", "report_date": "20200812", "code_info": "FG003181", "more_code_info": ""}, {"status": "Terminated", "city": "Oklahoma City", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85827", "recalling_firm": "PD-Rx Pharmaceuticals, Inc.", "address_1": "727 N Ann Arbor Ave", "address_2": "", "postal_code": "73127-5822", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "United States", "recall_number": "D-1307-2020", "product_description": "metFORMIN HCL ER USP 500 mg, a) 30 tablets (NDC: 43063-428-30); b) 60 tablets (NDC: 43063-428-60); c) 90 tablets (NDC: 43063-428-90); d) 120 tablets (NDC: 43063-428-98); e) 180 tablets (NDC: 43063-428-93); f) 500 tablets (NDC: 53746-0178-05), Rx only, PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127", "product_quantity": "3703 bottles", "reason_for_recall": "CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level", "recall_initiation_date": "20200605", "center_classification_date": "20200612", "termination_date": "20211108", "report_date": "20200624", "code_info": "Lots:  a) D19C80, F19C39, H19A55, H19D56, I18E0 Exp. 06/30/2020;     b) D19A66, E19C15, F19D60 Exp. 06/30/2020;     c) E19D32, J18B83, C19D25, C19E78, D19C60, D19D64, F19B27, G19A31, G19C41, I19A56 Exp. 06/30/2020;     d) E19C11, F19E33, I18E07 Exp. 06/30/2020;     e) D19D56, F19A51, H19A09, H19A81, H19B16, H19B77, H19C28, I18F43 Exp. 06/30/2020;     f) HF06618A, HF06718A Exp. 06/30/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0730-2020", "product_description": "FENTANYL 100MCG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@11 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1115-2020", "product_description": "De-Fibroidin, 500mg Capsules, 90-count bottles, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Spring", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85957", "recalling_firm": "Transliquid Technologies, LLC", "address_1": "330 Rayford Rd", "address_2": "N/A", "postal_code": "77386-1980", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-1408-2020", "product_description": "Mystic Shield PROTECTION, ALCOHOL ANTISEPTIC 70%, Topical Solution, Antiseptic Hand Rub, Non-sterile Solution, Extra strength Formula*, 8.45 fl. oz. (250 ml) bottle, Labeled with green or blue labels, Manufactured by Mystic Intl S.A. de C.V. UPC barcode: 7 87790 33952 6", "product_quantity": "20,340 bottles", "reason_for_recall": "Chemical Contamination: Presence of Undeclared Methanol", "recall_initiation_date": "20200629", "center_classification_date": "20200724", "termination_date": "20240313", "report_date": "20200729", "code_info": "Lots: All Lots", "more_code_info": ""}, {"status": "Terminated", "city": "Earth City", "state": "MO", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "86471", "recalling_firm": "Legacy Pharmaceutical Packaging LLC", "address_1": "13333 Lakefront Dr", "address_2": "N/A", "postal_code": "63045-1514", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Walmart distribution centers in GA and AR", "recall_number": "D-1626-2020", "product_description": "Metformin Hydrochloride Tablets USP, 1000 mg, 60-count bottles, Rx Only,  Manufactured for: Heritage Pharmaceuticals Inc., East Brunswick, NJ 08816,  Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045, Distributed by: Wal-Mart, Bentonville, AR 72716. NDC 68645-545-59", "product_quantity": "111,948 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: Metformin 1000mg with different imprint was found in bottles.", "recall_initiation_date": "20200924", "center_classification_date": "20200930", "termination_date": "20221108", "report_date": "20201007", "code_info": "Lot #: 201626, Exp. Date 08/2022"}, {"status": "Terminated", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA076217"], "brand_name": ["AMIODARONE HYDROCHLORIDE"], "generic_name": ["AMIODARONE HYDROCHLORIDE"], "manufacturer_name": ["Mylan Institutional LLC"], "product_ndc": ["67457-153"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["AMIODARONE HYDROCHLORIDE"], "rxcui": ["1663224", "1663244", "1663248"], "spl_id": ["bd9c578c-322f-41fc-936d-bf9b551a2782"], "spl_set_id": ["fcc8658c-761a-443f-8c32-1499d86028ec"], "package_ndc": ["67457-153-00", "67457-153-03", "67457-153-99", "67457-153-09", "67457-153-18"], "is_original_packager": [true], "unii": ["976728SY6Z"]}, "product_type": "Drugs", "event_id": "86247", "recalling_firm": "Mylan Institutional LLC", "address_1": "4901 Hiawatha Dr", "address_2": "N/A", "postal_code": "61103-1287", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1575-2020", "product_description": "Amiodarone Hydrochloride Injection, USP, 450 mg/9 mL (50 mg/mL), 9 mL Single-Dose Vial (NDC 67457-153-99); 10 x 9 mL Single-Dose Vials per carton (NDC 67457-153-09), Rx only, Manufactured by: Mylan Institutional, Galway, Ireland; Manufactured for: Mylan Institutional LLC, Rockford, IL  61103.", "product_quantity": "13,682 cartons", "reason_for_recall": "Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.", "recall_initiation_date": "20200817", "center_classification_date": "20200911", "termination_date": "20221228", "report_date": "20200909", "code_info": "Lot #: 191207, 191221, 191223 Exp. 11/2021; 200120 Exp. 12/2021"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0760-2020", "product_description": "MORPHINE 6MG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@19 Exp. 12/25/2019", "more_code_info": ""}, {"country": "United States", "city": "Allegan", "address_1": "515 Eastern Ave", "reason_for_recall": "CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.", "address_2": "", "product_quantity": "", "code_info": "Lots: 8EE1702,   8EE1703,   8EE1704,   8FE1724,   8GE1942,   8HE1396,   8HE1397,   8JE2156,   8KE2521,   8KE2523,   8LE2255,   8LE2665,   8LE2668,   9AE2541,   9AE2542,   9AE2543,   9BE2993,   9BE2994,   9BE2995,   9CE3735,   9CE3736,   9DE3108,   9DE3109,   9DE3110,   9EE2872,   9EE2880,   9FE3273,   9FE3276,   9GE2978,   9GE2979,   9HE3437,   9HE3438", "center_classification_date": "20200313", "distribution_pattern": "Nationwide USA", "state": "MI", "product_description": "Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 90 tablets per bottle. [Brand, NDC] NDC Equate: 49035-608-75; NDC Up & Up: 11673-023-75", "report_date": "20200325", "classification": "Class II", "openfda": {}, "recalling_firm": "Perrigo Company PLC", "recall_number": "D-1024-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84127", "termination_date": "20201106", "more_code_info": "", "recall_initiation_date": "20191023", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Polepally, Jadcherla", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86749", "recalling_firm": "Shilpa Medicare Limited", "address_1": "S-20 To S-26,  Pharm. Formulation Sez", "address_2": "Tsiic, Green Industrial Park", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0123-2021", "product_description": "Azacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx Only, One Single Dose Vial, Cytotoxic Agent, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals, Inc., Manalapan, NJ 07726, NDC 72606-558-01.", "product_quantity": "6,560 vials", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20201208", "center_classification_date": "20201209", "termination_date": "20220311", "report_date": "20201216", "code_info": "Lot #: 7S10227A, Exp. 10/31/2021"}, {"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85547", "recalling_firm": "QuVa Pharma, Inc.", "address_1": "1075 W Park One Dr Ste 100", "address_2": "N/A", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US.", "recall_number": "D-1335-2020", "product_description": "R.E.C.K. (Ropivacaine, Epinephrine, Clonidine, Ketorolac) in Sodium Chloride solution 50 mL in 60 mL Syringe, Compounded by QuVa 519 Bloombury, NJ 08804,  NDC 70092143350", "product_quantity": "17,050 syringes", "reason_for_recall": "Presence of Particulate Matter: Fresenius Kabi recalling vials of Ketorolac", "recall_initiation_date": "20200423", "center_classification_date": "20200623", "termination_date": "20210113", "report_date": "20200701", "code_info": "Lots: 30008721, Exp. 4/26/2020; 30008198, 30008554, Exp. 4/29/2020; 30008861, Exp. 4/30/2020; 30008859, Exp. 5/5/2020;  30008949, Exp. 5/10/2020; 30009073, Exp. 5/14/2020; 30009074, Exp. 30009138, Exp. 5/17/2020; 30009139, 30009227, Exp. 5/19/2020; 30009228, Exp. 5/20/2020; 30009387, 30009388, Exp. 5/27/2020; 30009410, 30009411, Exp. 5/28/2020; 30009413, Exp. 5/31/2020; 30009412,  30009489, Exp. 6/1/2020; 30009539, 30009563, Exp. 6/3/2020"}, {"status": "Terminated", "city": "Torrance", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84550", "recalling_firm": "Asclemed USA Inc. dba Enovachem Pharmaceuticals", "address_1": "379 Van Ness Ave Ste 1403", "address_2": "N/A", "postal_code": "90501-7211", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Product was distributed to 6 physician's offices within the state of California.", "recall_number": "D-0650-2020", "product_description": "Estriol, USP, (Micronized), 0.06 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-36", "product_quantity": "8.52 gm", "reason_for_recall": "Failed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results.", "recall_initiation_date": "20191209", "center_classification_date": "20200108", "termination_date": "20230809", "report_date": "20200115", "code_info": "Lot Code/Exp. Date: 11061901, 04011903, 04221904, 04241904,  06031902,  07301905, 09061903, EXP 12/31/2020"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86022", "recalling_firm": "4e Brands North America, Llc", "address_1": "17806 Ih-10 Ste 300", "address_2": "N/A", "postal_code": "78257", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0024-2021", "product_description": "blumen Clear ADVANCED HAND SANITIZER with 70% ALCOHOL, (ethyl alcohol 70% v/v), Packaged as a) 2 fl oz / 60 ml bottle, UPC 8 14266 02371 6 b) 7.5 fl oz / 221 ml bottle, UPC 8 14266 02362 4 c) 15.2 fl oz (450 ml) bottle, UPC 8 14266 02392 1, d) 17 fl oz / 503 ml bottle with blue cap or pump bottle, UPC 8 14266 02409 6, e) 18 fl oz / 532 ml bottle, UPC 8 14266 02391 4, f) 33.8 fl oz / 1 L straight or curved bottle, UPC 8 14266 02369 3  g) 70 fl oz / 2.07L bottle, UPC 8 14266 02367 9 h) 1.05 GAL / 4L bottle, UPC 8 14266 02368 6; Distributed in USA and Canada By: 4e Brands Northamerica LLC, 17806 IH-10W, Suite 300, San Antonio, Texas, 78257, Made in Mexico.", "product_quantity": "17,359,247 total bottles and pumps", "reason_for_recall": "CGMP Deviations: recalled because it was manufactured in the same facility as the product found to contain methanol which represents poor Current Good Manufacturing Practices.", "recall_initiation_date": "20200711", "center_classification_date": "20201007", "termination_date": "20240226", "report_date": "20201007", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Dayton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85212", "recalling_firm": "PharMEDium Services, LLC", "address_1": "36 Stults Rd", "address_2": "N/A", "postal_code": "08810", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-1081-2020", "product_description": "ePHEDrine Sulfate, 5 mg per mL, 50 mg per 10 mL,  In 0.9% Sodium Chloride 10 mL syringe, For IV Use Preservative Free PharMEDium 913 N. Davis Ave. Cleveland, MS NDC 71030-003-12", "product_quantity": "1075 units", "reason_for_recall": "Firm is recalling 46 lots of various products because of a lack of sterility assurance.", "recall_initiation_date": "20200316", "center_classification_date": "20200406", "termination_date": "20250214", "report_date": "20200415", "code_info": "193500004D  3/16/2020  193510006D   3/17/2020  193530011D  3/19/2020  193570003D 3/23/2020"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA208234"], "brand_name": ["DESFLURANE"], "generic_name": ["DESFLURANE"], "manufacturer_name": ["Sandoz Inc."], "product_ndc": ["0781-6172"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["DESFLURANE"], "rxcui": ["562366"], "spl_id": ["ecf9968e-58b0-4792-e053-2995a90aef25"], "spl_set_id": ["21ba0e18-3dbc-4feb-a3a4-f6470c00910a"], "package_ndc": ["0781-6172-22", "0781-6172-86"], "is_original_packager": [true], "upc": ["0307816172229"], "nui": ["N0000175975", "N0000175681"], "pharm_class_pe": ["General Anesthesia [PE]"], "pharm_class_epc": ["General Anesthetic [EPC]"], "unii": ["CRS35BZ94Q"]}, "product_type": "Drugs", "event_id": "86568", "recalling_firm": "eVenus Pharmaceutical Laboratories", "address_1": "506 Carnegie Ctr", "address_2": "Suite 100", "postal_code": "08540-6243", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CO only", "recall_number": "D-0042-2021", "product_description": "Desflurane, USP Liquid for Inhalation, 240 mL, Rx Only,  Manufactured by: Shanghai Hengrui Pharmaceutical Co., Ltd., Shanghai, 200245, China for Sandoz Inc. Princeton, NJ 08540, NDC 0781-6172-22", "product_quantity": "9210 units", "reason_for_recall": "DEFECTIVE CONTAINER: Desflurane Liquid for Inhalation 240 mL may be leaking.", "recall_initiation_date": "20201006", "center_classification_date": "20201020", "termination_date": "20220519", "report_date": "20201028", "code_info": "Lot #: 20011831, Exp. Date 12/2021; 20041431, Exp. Date 03/2022"}, {"status": "Terminated", "city": "South Richmond Hill", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85992", "recalling_firm": "MasterPharm LLC", "address_1": "11502 Liberty Ave Fl 2", "address_2": "N/A", "postal_code": "11419-1902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1427-2020", "product_description": "Progesterone (Modified Release) 150 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600", "product_quantity": "600 capsules", "reason_for_recall": "Lack of Processing Controls (lack of assurance of conformity to specifications).", "recall_initiation_date": "20200702", "center_classification_date": "20200729", "termination_date": "20240223", "report_date": "20200805", "code_info": "02-05-2020:07@6, BUD 8/3/2020"}, {"status": "Completed", "city": "Jenison", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85854", "recalling_firm": "MICHIGAN HERBAL REMEDIES", "address_1": "904 Chicago Dr", "address_2": "", "postal_code": "49428-9351", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide via internet sales,retailers and distributors in the USA", "recall_number": "D-1466-2020", "product_description": "SP, hemp oil, Spearmint, 300MG CBD, 1 FL. OZ (30 ML) bottles, Distributed by: The Spiffy Piff", "product_quantity": "25 bottles", "reason_for_recall": "Chemical contamination: product contains elevated levels of undeclared lead.", "recall_initiation_date": "20200618", "center_classification_date": "20200804", "report_date": "20200812", "code_info": "FG003276", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0776-2020", "product_description": "TRIMIX FORTE 30MG/2MG/20MCG/ML INJ in 1 mL vial  Assurance Infusion (713) 533-8800", "product_quantity": "358 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 08082019@7 Exp. 02/04/2020; 08232019@1 Exp. 02/19/2020; 07262019@12 Exp. 01/22/2020; 07012019@25 Exp. 12/28/2019; 07102019@14 Exp. 01/06/2020; 09202019@4 Exp. 03/18/2020; 10282019@23 Exp. 04/25/2020; 10092019@7 Exp. 03/04/2020; 08292019@11 Exp. 02/25/2020; 10042019@6 Exp. 04/01/2020; 10162019@20 Exp. 04/13/2020; 11062019@24 Exp. 03/04/2020; 12042019@20 Exp. 01/18/2020; 12102019@11 Exp. 01/24/2020; 12162019@36 Exp. 01/30/2020; 11262019@29 Exp. 01/10/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86066", "recalling_firm": "Ferring Pharmaceuticals Inc", "address_1": "100 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States.", "recall_number": "D-1504-2020", "product_description": "DDAVP Nasal Spray (desmopressin acetate) 10 mcg/0.1 mL, 5 mL bottles, Rx Only, Mfd for: Ferring Pharmaceuticals Inc., Parsippany, NJ 07054 USA, NDC 55566-2500-0", "product_quantity": "15,175 nasal sprays", "reason_for_recall": "Superpotent Drug", "recall_initiation_date": "20200721", "center_classification_date": "20200817", "termination_date": "20231013", "report_date": "20200826", "code_info": "Lot #: N14695F, exp. date 08/2020 N15627C, exp. date 10/2020 P11319P, exp. date 01/2021 P11706F, exp. date 04/2021 R11842C, exp. date 03/2022;  R13637E, exp. date 06/2022"}, {"status": "Ongoing", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85781", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "N/A", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1353-2020", "product_description": "amneal Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 1000 tablets bottles, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Ahmedabad, 388213, INDIA Distributed by: Amneal Pharmaceuticals LLC Bridgewater, NJ 08807   NDC  65162-0178-11", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level", "recall_initiation_date": "20200529", "center_classification_date": "20200625", "report_date": "20200701", "code_info": "HF08618A 6/30/2020  HF08718A 6/30/2020  HF15418A 7/31/2020  HF15518A 7/31/2020  HH11818A 9/30/2020  HJ00818A 9/30/2020  HJ00918A 9/30/2020  HJ01018A 9/30/2020"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84527", "recalling_firm": "MPRX, Inc. dba Medical Park Pharmacy", "address_1": "8230 Elmbrook Dr Ste 600b", "address_2": "N/A", "postal_code": "75247-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0809-2020", "product_description": "Magic Bullet Supplement", "product_quantity": "1 bottles", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.", "recall_initiation_date": "20191218", "center_classification_date": "20200129", "termination_date": "20221213", "report_date": "20200205", "code_info": "Lot: 61048:99 Use by: 02/08/2020"}, {"country": "United States", "city": "Miami", "address_1": "7715 NW 64th St", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "address_2": "", "product_quantity": "5387 6 Fl Oz bottles", "code_info": "Lot: 19F332 Exp. June 2022", "center_classification_date": "20200214", "distribution_pattern": "Distributed Nationwide in the USA", "state": "FL", "product_description": "Rompe Pecho EX Expectorant,  6 FL. Oz (178 mL) bottle, Distributed by: Efficient Laboratories, Inc. Miami, FL 33166. UPC 0 00856 30106 1", "report_date": "20200219", "classification": "Class II", "openfda": {}, "recalling_firm": "Efficient Laboratories, Inc.", "recall_number": "D-0846-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84864", "termination_date": "20201022", "more_code_info": "", "recall_initiation_date": "20200131", "postal_code": "33166-2719", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0758-2020", "product_description": "MORPHINE 4MG/ML  INJ in 20mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "3 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12112019@24 Exp. 12/20/2019; 12122019@1 Exp. 12/21/2019; 12122019@2 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Baudette", "state": "MN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA205401"], "brand_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "product_ndc": ["43975-277", "43975-278", "43975-279", "43975-280", "43975-282", "43975-281"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMPHETAMINE DL-ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "rxcui": ["861221", "861223", "861225", "861227", "861232", "861237"], "spl_id": ["d0db10e9-cc85-492d-9f29-663948539b07"], "spl_set_id": ["6438480f-1147-42b6-826d-4e1e1f8ff007"], "package_ndc": ["43975-277-10", "43975-278-10", "43975-279-10", "43975-280-10", "43975-282-10", "43975-281-10"], "is_original_packager": [true], "upc": ["0343975282102", "0343975281105", "0343975278105", "0343975280108", "0343975277108", "0343975279102"], "unii": ["O1ZPV620O4", "G83415V073", "JJ768O327N", "6DPV8NK46S"]}, "product_type": "Drugs", "event_id": "86584", "recalling_firm": "ANI Pharmaceuticals, Inc.", "address_1": "455 Idc Rd Sw", "address_2": "N/A", "postal_code": "56623-2467", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0045-2021", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 15 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-279-10", "product_quantity": "13248 bottles", "reason_for_recall": "Labeling: Incorrect expiration date.  Product dated with 24-month expiration date instead of 18-months.", "recall_initiation_date": "20201009", "center_classification_date": "20201021", "termination_date": "20220119", "report_date": "20201028", "code_info": "Lot: 19T14 Exp. Dec. 2021, 20D06 Exp. Apr. 2022"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0932-2020", "product_description": "Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection, 18 mcg/1.8mg/0.2mg/0.02mg/mL, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0547-2", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 12042019+533247, Exp 1/17/2020"}, {"status": "Completed", "city": "Jenison", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85854", "recalling_firm": "MICHIGAN HERBAL REMEDIES", "address_1": "904 Chicago Dr", "address_2": "", "postal_code": "49428-9351", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide via internet sales,retailers and distributors in the USA", "recall_number": "D-1453-2020", "product_description": "Made by Hemp 1000MG Hemp Extract, Strawberry Creme, 1 OZ (30 ML) bottles, Dist by: MHR Brands, Jenison, MI,  UPC 8 02991 76554 4", "product_quantity": "496 bottles", "reason_for_recall": "Chemical contamination: product contains elevated levels of undeclared lead.", "recall_initiation_date": "20200618", "center_classification_date": "20200804", "report_date": "20200812", "code_info": "FG003109", "more_code_info": ""}]